O-chloroacetylcarbamoyl fumagillol combined with 5-fluorouracil in suppression of the growth of gastric cancer

宋震亚,彭佳萍,朱永良,钱可大,郑树
2003-01-01
Abstract:AIM: To evaluate the feasibility and anti-tumor effect of combined therapy of O-chloroacetylcarbamoyl fumagillol (TNP-470) and 5-fluorouracil (5-FU) in nu/nu mice model of human gastric cancer. METHODS: Thirty two BALB/c nu/nu mice, which had been inoculated human gastric adenocarcinoma cell line subcutaneously, were divided into four groups and received treatment subcutaneously every other day. (1) TNP-470 50 mg·kg-1, (2) 5-FU 30 mg·kg-1, (3) TNP-470 50 mg·kg-1 + 5-FU 30 mg·kg-1 (4) TNP-470 vehicle (3% ethanol plus 5% gum arabic in saline). The volume of transplanted tumors were measured every week, after 4 weeks, the nude mice were sacrificed and the tumors were immediately removed for testing the VEGF165 mRNA by RT-PCR and microvessel density (MVD) by streptavidin-alkaline phosphatase staining method. RESULTS: The tumor suppression rates at 4 weeks after inoculation were 98.8%, 69.7% and 86.7%, respectively, in the three treated groups, otherwise the tumor volume in combinated group was more smaller than in other two groups at 3 weeks, combination therapy of TNP-470 with 5-FU showed more marked inhibition on the growth of gastric cancer. But the expression of VEGF165 mRNA among the four groups had no significant difference (P > 0.05). MVD in the four groups were 3.8 ± 0.6, 8.8 ± 4.8, 4.8 ± 0.4, 8.8 ± 1.3, respectively, the MVD in TNP-470 group and combined one were lower than the other two groups (P < 0.05), indicating that TNP-470 could inhibit the neovascularization in gastric cancer, whereas 5-FU could not. CONCLUSION: Combination therapy of TNP-470 with 5-FU shows more remarkable inhibition on the growth of transplanted gastric cancer in nude mice than single therapy of TNP-470 or 5-FU.
What problem does this paper attempt to address?